Cancer drama involving Munich woman: Manufacturer takes medication off the market – “lost without a daughter and a doctor’s help” Munich's top lung cancer expert is horrified: Drug manufacturer is taking cancer drug from the market that could give one of its patients a lifetime. The reason: A dispute over money at the expense of the sick! Munich - It's a shock: The cancer drug capmatinib, which the lung cancer patient Dr.
Ruth B. tolerated it very well and has been keeping her tumor in her lungs at bay since May 2023, and the manufacturer Novartis has taken it off theMarket in Germany.